Markets:

Overview

News

Currencies

International

Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

66.55 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs ↗

February 28, 2022

Medical imaging Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 96.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 25, 2022

Gainers Aerie Pharmaceuticals (NASDAQ:AERI) shares increased by 28.1% to $7.56 during Friday's regular session. Trading volume for Aerie Pharmaceuticals's stock is...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Surges 2%; South Jersey Industries Shares Spike Higher ↗

February 24, 2022

U.S. stocks pared some earlier losses toward the end trading, with the Nasdaq jumping 2% on Thursday. US President Biden, during his press briefing on Ukraine/Russia, said he...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

March 03, 2022

On Thursday, 95 companies set new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to break to a new 52-week high...

Via Benzinga

93 Biggest Movers From Friday ↗

February 28, 2022

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...

Via Benzinga

88 Biggest Movers From Yesterday ↗

February 25, 2022

Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 24, 2022

Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...

Via Benzinga

Mid-Day Market Update: Dow Drops Over 500 Points; Crude Oil Surges 6% ↗

February 24, 2022

U.S. stocks remained lower midway through trading on Thursday after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

February 24, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....

Via Benzinga

Mid-Morning Market Update: US Markets Open Lower Amid Russian Military Action In Ukraine ↗

February 24, 2022

U.S. stocks opened on a downbeat note this morning after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a “special...

Via Benzinga

Investors Cheer Lantheus' Wall Street-Beating FY22 Outlook ↗

February 24, 2022

Lantheus Holdings Inc (NASDAQ: LNTH) reported Q4 sales of $129.6 million, +37.6% Y/Y, beating the consensus of $111.76 million. The company's Q4 adjusted EPS...

Via Benzinga

How Good Are Lantheus Holdings's Earnings? | Return On Capital Employed ↗

November 08, 2021

According to Benzinga Pro data, during Q3, Lantheus Holdings (NASDAQ:LNTH) posted sales of $102.07 million. Earnings were up 46.5%, but Lantheus Holdings still reported an overall...

Via Benzinga

Lantheus Holdings, Inc (LNTH) Q3 2021 Earnings Call Transcript ↗

November 07, 2021

LNTH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Return on Capital Employed Overview: Lantheus Holdings ↗

August 04, 2021

After pulling data from Benzinga Pro it seems like during Q2, Lantheus Holdings (NASDAQ:LNTH) brought in sales totaling $101.06 million. However, earnings decreased 7559.89%,...

Via Benzinga

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Lantheus Announces the First and Only FDA Cleared AI-Enabled PSMA Digital Application, aPROMISE™, Strengthening Lantheus’ Leadership in Prostate Cancer

July 29, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Lantheus Holdings, inc (LNTH) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

LNTH earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Lantheus Stock Gains As Q2 Earnings Surpasses Expectations; Raises FY2021 Outlook ↗

July 28, 2021

Lantheus Holdings Inc (NASDAQ: LNTH) clocked $101.1 million in sales for Q2 of 2021, beating the consensus of $94.9 million, representing an increase of 53.1% Y/Y. Sales...

Via Benzinga

Lantheus Holdings: Q2 Earnings Insights ↗

July 28, 2021

Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 10.00% over the past...

Via Benzinga

Lantheus Holdings, Inc. Reports Second Quarter 2021 Financial Results

July 28, 2021

From Lantheus Holdings, Inc.

Via Business Wire

Earnings Preview: Lantheus Holdings ↗

July 27, 2021

On Wednesday, July 28, Lantheus Holdings (NASDAQ:LNTH) will release its latest earnings report. Decipher the announcement with Benzinga's help. Net Income, Earnings, And Earnings...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Lantheus Holdings to Host Second Quarter 2021 Earnings Conference Call and Webcast on July 28, 2021 at 8:00 a.m. Eastern Time

July 14, 2021

From Lantheus Holdings, Inc.

Via Business Wire

The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures ↗

July 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗

June 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 29, 2021

Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was...

Via Benzinga

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs ↗

June 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.